Stock Alert: OptiNose Gains 23%

(RTTNews) - OptiNose Inc. (OPTN) shares are rising more than 15 percent on Friday morning, though there were no major announcements from the specialty pharmaceutical company.

The company specializing in the ears, nose, and throat and allergy has been trying to market innovative products to improve the quality of life of patients. Earlier on July 8, the company has announced an agreement with Kaleo to co-promote XHANCE exhalation nasal spray 93 mcg for the treatment of nasal polyps in patients of more than 18 years. The shares have been gaining since then on a higher volume.

Currently OPTN is trading at $5.95, up 23.08 percent from its previous close of $5.24.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


    Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

    Learn More